Author Archive: Roy Zwahlen

Roy Zwahlen

Roy is Associate Counsel at BIO and the main contributor for Patently Biotech. He is a lawyer by training, with a background in international and national politics. He grew up in the developing world and believes that innovation can and does solve many of the world’s problems. Because of this, his work focuses on creating a worldwide policy environment that fosters innovation in the biotechnology sector to prevent and cure diseases such as HIV, to increase crop yields to feed more people, and to decrease the harmful effects of industry on the environment. Roy spends his free time keeping up with his three kids, a wife that knows everything (no joke), and serving in his church and broader community. Learn more about Roy from his Linkedin Profile.

Latest Posts

Where Breakthroughs Will Soon Call Home: Wisconsin’s BioAg Gateway

The Wisconsin BioAg Gateway is a visionary project being sited on Madison’s southeast side at the crossroads of Interstates 90 and 94.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Boosting Small Company Presence at 2010 BIO International Convention, Wisconsin Madison Region Shows Off Talent

In 2010, 10 Wisconsin biotech companies were awarded scholarships of $1,100 each out of the grant partnership to help small Wisconsin biotech companies in medical, agriculture, energy, or other sectors, including medical devices, to participate in the Biotechnology Industry Organization’s International Convention One-on-One Partnering or company presentation forums. Nine of those 10 companies are located in the eight-county Madison Region.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,

Burrill Report Podcast: Implications of Gene Patent Ruling

The Burrill Report podcast on the impact of the recent decision invalidating patents on genetic materials.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

From Lab to Commercialization: NIH Licenses Offer Another Path

If a biomedical breakthrough occurs within a federal lab, chances are your company can license use of the technology from the National Institutes of Health’s Office of Technology Transfer (OTT).

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , ,

Tomorrow: BIO is “To the Point” on Gene Patenting

BIO is participating in an NPR segment at approximately 2:08pm ET tomorrow on the nationally-syndicated national radio program “To the Point” which originates in NYC. It should air on WAMU in DC, too, for those of you in the Nation’s capital.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: ,